TRAF2 overexpression has been documented in tumor samples from certain types of cancer such as human pancreatic cancer, breast cancer and gastric cancer, and is associated with cancer progression, metastasis, and shorter patient survival [23, 25, 26]. This evidence concerns the gene TRAF2 and cancer.